Grading and scoring in histopathology

Histopathology

Volumn 33, Issue 2, 1998, Pages 99-106

  Cross, S S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Classification; Diagnosis; Grading; Histopathology; Scoring

Indexed keywords

BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER GRADING; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SCORING SYSTEM;

DISEASE MANAGEMENT; HUMANS; NEOPLASM STAGING; NEOPLASMS; OBSERVER VARIATION; PATHOLOGY; PROGNOSIS;

EID: 0031838828     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1998.00495.x     Document Type: Review

References (26)

1. Foucar E. Do pathologists play dice? Uncertainty and early histopathological diagnosis of common malignancies. Histopathology 1997; 31; 495-502.
2. Underwood JCE. Introduction to Biopsy Interpretation and Surgical Pathology. London: Springer-Verlag, 1987.
3. Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998; 32; 393-398.
4. Elston CW. Grading of invasive carcinoma of the breast. In: Page DL, Anderson TJ, eds. Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 1987; 300-311.
5. Oates GD, Finan PJ, Marks CG et al. Handbook for the Clinico-Pathological Assessment and Staging of Colorectal Canter. 2nd edn. London: UK Co-ordinating Committee on Cancer Research. 1997; 13-26.
6. Shepherd NA, Quirke P. Colorectal cancer reporting: are we failing the patient? J. Clin. Pathol. 1997; 50; 266-267.
7. Feinstein AR. Multivariable Analysis. New Haven: Yale University. 1996.
8. Ismail SM, Colclough AB, Dinnen JS et al. Reporting cervical intra-epithelial neoplasia (CIN): intra- and interpathologist variation and factors associated with disagreement. Histopathology 1990; 16; 371-376.
9. Morris JA. Information and observer disagreement in histopathology. Histopathology 1994; 25; 123-128.
10. Scheuer PJ. Chronic hepatitis: what is activity and how should it be assessed? Histopathology 1997; 30; 103-105.
11. Ishak K, Baptista A, Bianchi L, Smith AB. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995; 22; 696-699.
12. Silcocks PB. Measuring repeatability and validity of histological diagnosis: a brief review with some practical examples. J. Clin. Pathol. 1983; 36; 1269-1275.
13. Silcocks PB. Some issues in observer error studies in pathology. J. Pathol. 1992; 168; 255-256.
14. Cross SS. Kappa statistics as indicators of quality assurance in histopathology and cytopathology. J. Clin. Pathol. 1996; 49; 597-599.
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33; 159-174.
16. Sorensen FB, Sasaki M, Fukuzawa S, Yamabe H, Olsen S, Yoshida O. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility. Lab. Invest. 1994; 70; 242-254.
17. Lessells AM, Burnett RA, Howatson SR et al. Observer variability in the histopathological reporting of needle biopsy specimens of the prostate. Hum. Pathol. 1997; 28; 646-649.
18. Brown LJR, Smeeton NC, Dixon MF. Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J. Clin. Pathol. 1985; 38; 174-179.
19. Thomas GDH, Dixon MF, Smeeton NC, Williams NS. Observer variation in the histological grading of rectal carcinoma. J. Clin. Pathol. 1983; 36; 385-391.
20. Kay EW, O'Dowd J, Thomas A et al. Mild abnormalities in liver histology associated with chronic hepatitis: distinction from normal liver histology. J. Clin. Pathol. 1997; 50; 929-931.
21. Blamey RW, Davies CJ, Elston CW, Johnson J, Haybrittle JL, Maynard PV. Prognostic factors in breast cancer: the formation of a prognostic index. Clin. Oncol. 1979; 5; 227-236.
22. Haybrittle JL, Blamey RW, Elston CW et al. A prognostic index in primary breast cancer. Br. J. Cancer 1982; 45; 361-366.
23. Pinder SE. Ellis IO, Elston CW. Prognostic factors in primary breast carcinoma. J. Clin. Pathol. 1995; 48; 981-983.
24. Jannink I, Risberg B, van Diest PJ, Baak JPA. Heterogeneity of mitotic activity in breast cancer. Histopathology 1996; 29; 421-428.
25. Cross SS, Start RD. Estimating mitotic activity in tumours. Histopathology 1996; 29; 485-488.
26. Kaserer K, Fiedler R, Steindl P, Muller CH, Wrba F, Ferenci P. Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C. Histopathology 1998; 32; 454-461.